View Archive

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 3.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from MorphoSys AG.

ASH: Emerging Paradigms to Address Unmet Needs in Relapsed/Refractory DLBCL

ASH: Emerging Paradigms to Address Unmet Needs in Relapsed/Refractory DLBCL

Friday, December 6, 2019
1:30 PM – 4:30 PM
Lunch and registration: 12:30 PM – 1:30 PM

Rosen Centre Hotel
Lunch: Grand Ballroom C, Ballroom Level
Meeting Room: Grand Ballroom C, Ballroom Level
9840 International Drive
Orlando, FL 32819
Phone: (407) 996-9840


Emerging Paradigms to Address Unmet Needs in Relapsed/Refractory DLBCL will bring you expert perspectives on managing challenges in treating patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL). You will learn about the disease continuum, including state-of-the-art approaches in risk classification and selection of therapy. Although first-line chemoimmunotherapy is the current standard of care for patients with newly diagnosed DLBCL, approximately half of the patients will experience either disease relapse or refractory disease. Stem-cell transplant plays an important role in the management of these patients; however, many patients are not candidates for transplant due to age, comorbidities, and other factors, creating an unmet medical need. In this activity, you will also learn about cutting-edge approaches in development for transplant-ineligible patients with relapsed/refractory DLBCL, including antibodies targeting novel cell-surface antigens, inhibitors of B-cell receptor signaling, and cellular immunotherapy. Throughout the program, expert discussion panels will illustrate emerging approaches for patients with relapsed/refractory DLBCL, as well as review related abstracts to be presented in Orlando. Be sure to join us for this exciting opportunity to improve your practice.

Benefits of Attending:

  • See how top experts assess risk and manage patients with DLBCL
  • Gain expert insights into treatment of transplant-ineligible patients with relapsed/refractory DLBCL
  • Develop strategies to manage therapy-related adverse events
  • Learn about emerging agents for patients with relapsed/refractory DLBCL

Acknowledgement of Commercial Support

This activity is supported by an educational grant from MorphoSys AG.

Target Audience

This educational activity is directed toward medical oncologists/hematologists, nurse practitioners, nurses, and fellows who treat patients with DLBCL. Physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of DLBCL are also invited to participate.

Learning Objectives

  • Describe current standards of care and outcomes for patients with DLBCL
  • Summarize unmet clinical needs and methods to assess risk in patients with DLBCL
  • Explain novel mechanisms of action and therapeutic targets for patients with newly diagnosed or relapsed/refractory DLBCL
  • Evaluate the efficacy and adverse event profile of emerging approaches for patients with relapsed/refractory DLBCL

Program Chair

Gilles A. Salles
Gilles A. Salles, MD, PhD
Professor of Medicine and Hematology
Claude Bernard University of Lyon
Head of the Department of Hematology
Lyon-Sud University Hospital Complex
Pierre-Bénite, France

ASH CME Programs


2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

In case of onsite emergency:

Professional Information


Calendar of Events
Filter By